Name | BMS-986299 |
---|
Description | BMS-986299 (compound 112) is a first-in-class NLRP3 inflammasome agonist with an EC50 of 1.28 μM. (patent WO2018152396A1). |
---|---|
Related Catalog | |
Target |
NLRP3:1.28 μM (EC50) |
References |
[1]. Gary Glick, et al. Substituted imidazo-quinolines as nlrp3 modulators. WO2018152396A1. |
Molecular Formula | C18H19N7O |
---|---|
Molecular Weight | 349.39 |